The Iong and short of it

130/30: worth it? Discuss. David Walker asked some experts ..

Short-extension strategies are increasingly liked by investors and most definitely beloved of marketing departments. But are they worth it?

Andrea Angelone, head of the equity finance desk at JPMorgan's equity derivatives group, and Neil Taylor, executive director, equity finance, from JPMorgan, note that while launching into 130/30 - either from the pure hedge fund side of the fund management industry or the traditional long-only side - brings additional opportunities, those making the leap

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here